The Innovation (Nov 2021)

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?

Lei Zhao,
Wu Zhong

Affiliations

Lei Zhao: National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China
Wu Zhong: National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; Corresponding author

DOI: https://doi.org/10.1016/j.xinn.2021.100165
Journal volume & issue: Vol. 2, no. 4
p. 100165

Abstract

No abstracts available.

Published in The Innovation

ISSN: 2666-6758 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Science: Science (General)
Website: https://www.cell.com/the-innovation

About the journal